List of Studies ( Metabolite:5,5-Diethylbarbituric acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002759 | AN004479 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
| ST002760 | AN004483 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004489 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
| ST001658 | AN002706 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | Peak area |
| ST001658 | AN002708 | Control of Topoisomerase II Activity and Chemotherapeutic Inhibition by TCA Cycle Metabolites | Yeast cells | Yeast | Cancer | Johns Hopkins University | Peak area |
| ST001122 | AN001847 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | Urine | Human | Interstitial cystitis | University of California, Davis | Peak height |
| ST000549 | AN000839 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Blood | Mouse | Diabetes | Mayo Clinic | Peak intensity |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
